Latest other current liabilities for THAR: $740K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Tharimmune (THAR) currently reports a other current liabilities of $740K as of March 2026. That compares with $800K in the prior-year period — down 7.6% year over year. Use the charts on this page to explore Tharimmune's other current liabilities history and peer comparisons.
Tharimmune's other current liabilities decreased from $800K to $740K — a 7.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Tharimmune reported $740K in other current liabilities as of March 2026. That compares with $800K in the prior-year period — down 7.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current liabilities of $740K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tharimmune, and consider following THAR for alerts when major investors trade the stock.
Tharimmune is classified in the Healthcare sector. On other current liabilities, it currently shows $740K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing THAR with unrelated industries.